|
EIF2S2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.851900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.205990E-01 |
| Normal-vs-Stage2 |
3.997800E-01 |
| Normal-vs-Stage3 |
3.043000E-01 |
| Normal-vs-Stage4 |
2.898700E-03 |
| Stage1-vs-Stage2 |
6.964600E-01 |
| Stage1-vs-Stage3 |
7.569200E-01 |
| Stage1-vs-Stage4 |
2.606300E-02 |
| Stage2-vs-Stage3 |
9.338400E-01 |
| Stage2-vs-Stage4 |
3.461700E-02 |
| Stage3-vs-Stage4 |
2.988400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.105800E-02 |
| Normal-vs-AfricanAmerican |
2.874400E-01 |
| Normal-vs-Asian |
6.089000E-01 |
| Caucasian-vs-AfricanAmerican |
6.443400E-01 |
| Caucasian-vs-Asian |
9.125200E-01 |
| AfricanAmerican-vs-Asian |
7.552400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.724500E-02 |
| Normal-vs-Female |
1.149040E-01 |
| Male-vs-Female |
5.425600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.319200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.550300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.813710E-02 |
| Normal-vs-Age(81-100Yrs) |
7.417800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.097200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.455000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.160400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.143000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.344800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.632400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.398200E-01 |
| Normal-vs-Grade 2 |
6.380500E-02 |
| Normal-vs-Grade 3 |
3.323200E-01 |
| Normal-vs-Grade 4 |
2.475300E-03 |
| Grade 1-vs-Grade 2 |
8.239400E-01 |
| Grade 1-vs-Grade 3 |
5.775800E-01 |
| Grade 1-vs-Grade 4 |
1.808770E-01 |
| Grade 2-vs-Grade 3 |
3.110000E-01 |
| Grade 2-vs-Grade 4 |
3.033800E-02 |
| Grade 3-vs-Grade 4 |
9.121000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.107400E-01 |
| Normal-vs-ccB subtype |
7.374400E-02 |
| ccA subtype-vs-ccB subtype |
3.486800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.724000E-02 |
| Normal-vs-N1 |
1.118210E-01 |
| N0-vs-N1 |
2.583400E-01 |
|
|
